2015 ESC/ERS PH guidelineshttps://academic.oup.com/eurheartj/article/37/1/67/2887599
World Symposium on Pulmonary Hypertension (WSPH)http://www.wsphassociation.org/
Uptravi® Israel PIhttps://data.health.gov.il/drugs/index.html#!/byDrug
Download Uptravi® slides
Details of the GRIPHON study, where the safety and efficacy of UPTRAVI® were investigated in a Phase 3 study to assess the long-term benefits for pulmonary arterial hypertension (PAH) patients.
A synopsis of the key benefits of UPTRAVI® in the treatment of PAH.